Exhibit 23.1
ELITE PHARMACEUTICALS, INC AND SUBSIDIARIES
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following documents of our reports dated June 15, 2016, relating to the consolidated financial statements and management’s assessment of internal control over financial reporting of Elite Pharmaceuticals, Inc. and Subsidiary as well as included in the Annual Report on Form 10-K of the Company for the year ended March 31, 2016 and Form S-3 as filed with the Securities and Exchange Commission on May 10, 2017. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
Registration Statement No. 333-197694 on Form S-8 dated July 29, 2014
Registration Statement No. 333-163907 on Form S-8 dated December 22, 2009
Buchbinder Tunick & Company LLP
/s/ Buchbinder Tunick & Company LLP
Wayne, New Jersey
May 10, 2017
